| Q50971224 | Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia. |
| Q43638427 | Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment |
| Q52010904 | Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine. |
| Q44317531 | Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers |
| Q51128978 | Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: Associated clinical features |
| Q73731756 | Paroxetine binding in aggressive schizophrenic patients |
| Q73531886 | Platelet paroxetine binding in post-traumatic stress disorder |
| Q42939547 | Platelet serotonergic markers in psychiatric disorders: use, abuse and limitations |
| Q51090506 | Platelet serotonin functions in untreated major depression. |
| Q73894326 | Platelet serotonin measures in adolescents with conduct disorder |
| Q44071086 | Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures |
| Q44380074 | Relationship between platelet serotonin uptake sites and treatment outcome among African-American cocaine dependent individuals |
| Q48524555 | Repeated antidepressant drug treatment, time of death and frequency of handling do not affect [3H]paroxetine binding in rat cortex |
| Q35692262 | Serotonergic platelet markers of suicidal behavior--do they really exist? |
| Q74297253 | Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity |